We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+11.43%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$43.4B
AUM Growth
+$3.14B
(+7.8%)
Cap. Flow
-$115M
Cap. Flow
% of AUM
-0.27%
Top 10 Holdings %
Top 10 Hldgs %
13.22%
Holding
2,192
New
164
Increased
795
Reduced
936
Closed
172
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$193M |
| 2 |
Gilead Sciences
GILD
|
+$115M |
| 3 |
Tencent Music
TME
|
+$83.5M |
| 4 |
Kanzhun
BZ
|
+$76.7M |
| 5 |
Wheaton Precious Metals
WPM
|
+$68.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$189M |
| 2 |
Williams Companies
WMB
|
+$155M |
| 3 |
AYX
Alteryx Inc
AYX
|
+$94.1M |
| 4 |
AbbVie
ABBV
|
+$87M |
| 5 |
Amgen
AMGN
|
+$78.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.44% |
| 2 | Healthcare | 17.1% |
| 3 | Financials | 12.78% |
| 4 | Industrials | 10.38% |
| 5 | Consumer Discretionary | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Charter Communications
CHTR
$16.1B
| $160K | ﹤0.01% |
551
+22
| +4% | +$7.07K |
|
1527
Acadia Pharmaceuticals
ACAD
$4.75B
| $160K | ﹤0.01% |
8,648
-83,695
| -91% | -$2.07M |
|
1528
Ventas
VTR
$45.2B
| $160K | ﹤0.01% |
3,665
-939
| -20% | -$42.7K |
|
1529
Regions Financial
RF
$24.3B
| $160K | ﹤0.01% |
7,584
-1,097
| -13% | -$20.7K |
|
1530
Air Products & Chemicals
APD
$63.9B
| $158K | ﹤0.01% |
653
-92
| -12% | -$22.5K |
|
1531
Clearway Energy Class C
CWEN
$6.15B
| $157K | ﹤0.01% |
6,817
-260
| -4% | -$6.11K |
|
1532
PENN Entertainment
PENN
$2.37B
| $155K | ﹤0.01% |
8,512
-10,408
| -55% | -$215K |
|
1533
CDW
CDW
$18.7B
| $154K | ﹤0.01% |
604
+24
| +4% | +$5.7K |
|
1534
PG&E
PCG
$29.4B
| $152K | ﹤0.01% |
9,082
-7,122
| -44% | -$119K |
|
1535
Pennant Group
PNTG
$1.48B
| $152K | ﹤0.01% |
+7,721
| New | +$130K |
|
1536
Diamondback Energy
FANG
$54.5B
| $151K | ﹤0.01% |
764
+511
| +202% | +$86.8K |
|
1537
Waterstone Financial
WSBF
$374M
| $151K | ﹤0.01% |
12,404
-120,593
| -91% | -$1.53M |
|
1538
Diamondrock Hospitality Co
DRH
$2.51B
| $148K | ﹤0.01% |
15,432
+13,904
| +910% | +$130K |
|
1539
Schrodinger
SDGR
$1.79B
| $146K | ﹤0.01% |
5,400
+1,400
| +35% | +$39.1K |
|
|
WSR
1540
DELISTED
Whitestone REIT
WSR
| $146K | ﹤0.01% |
11,604
-244
| -2% | -$3.02K |
|
1541
Quaker Houghton
KWR
$2.65B
| $146K | ﹤0.01% |
+709
| New | +$141K |
|
1542
Nicolet Bankshares
NIC
$3.52B
| $142K | ﹤0.01% |
1,653
| – | – |
|
1543
Ivanhoe Electric
IE
$1.43B
| $141K | ﹤0.01% |
+14,400
| New | +$124K |
|
1544
Alto Neuroscience
ANRO
$1.18B
| $138K | ﹤0.01% |
+9,000
| New | +$141K |
|
1545
Heron Therapeutics
HRTX
$60.3M
| $138K | ﹤0.01% |
+49,700
| New | +$125K |
|
|
BTAI
1546
DELISTED
BioXcel Therapeutics
BTAI
| $135K | ﹤0.01% |
+2,994
| New | +$143K |
|
|
FLG
1547
Flagstar Bank National Association
FLG
$5.22B
| $133K | ﹤0.01% |
13,761
-10,161
| -42% | -$188K |
|
1548
Boston Properties
BXP
$10.2B
| $132K | ﹤0.01% |
2,014
-1,983
| -50% | -$131K |
|
|
OSG
1549
Octave Specialty Group
OSG
$213M
| $131K | ﹤0.01% |
8,378
-67,756
| -89% | -$1.07M |
|
|
VMRK
1550
Vivmark Residential
VMRK
$48.7B
| $127K | ﹤0.01% |
2,017
-29
| -1% | -$1.76K |
|
Similar funds
Federated Hermes's Q1 2024 Portfolio in Review
As of Q1 2024, Federated Hermes held 2,192 positions worth $43.4B, up 7.8% from $40.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes's Q1 2024 filing shows 164 new, 795 increased, 936 reduced and 172 closed positions. Its largest new stake was Kanzhun: 4,861,533 shares worth $85.2M. The largest sale was Medtronic, an estimated $189M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q1 2024 buy was Kanzhun: 4,861,533 shares worth $85.2M.
- Federated Hermes added most to Bristol-Myers Squibb in Q1 2024, an estimated $193M increase.
- Federated Hermes's biggest Q1 2024 reduction was Medtronic, cutting an estimated $189M.
- Federated Hermes fully exited Alteryx Inc in Q1 2024, selling an estimated $94.1M.
- Federated Hermes's ten largest holdings make up 13% of its $43.4B portfolio in Q1 2024.
- Federated Hermes opened 164 new positions and closed 172 in Q1 2024.
- Federated Hermes's portfolio value rose 7.8% quarter-over-quarter to $43.4B.
Based on Federated Hermes's 13F filing for Q1 2024, filed 14 May 2024.